Shire acquires German biotech
Shire Ltd has bought Jerini AG for €328million, widening its footprint in human genetic therapies.
SkyePharma shares soar
SkyePharma plc shares up 6% in London trading after experimental asthma inhaler Flutiform meets goals of phase III study.
AstraZeneca shares rise 7%
Shares of AstraZeneca plc, the UK's second largest drugmaker, rose the most in five years this morning, July 2, after a US court upheld a patent on its Seroquel antipsychotic, the company's second bestselling product.
GSK cancer vaccine Cervarix faces further delays
GlaxoSmithKline plc said on Monday, June 30, that it does not expect to win US approval for the company's experimental cervical cancer vaccine Cervarix until late 2009.
Southern Cross finance chief to leave; cuts forecast
Southern Cross Healthcare Group Plc, the UK's largest care-home operator, said on Monday, June 30, Finance Director Jason Lock was leaving with immediate effect and would be replaced by Richard Midmer.
MedImmune CEO Mott to step down, says Astra Zeneca
Astra Zeneca plc said Thursday, June 26, that David Mott, President and CEO of MedImmune, its biologics business unit, will leave the company at the end of July.